Figure S17 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response
Sanya Mehta(St. Jude Children's Research Hospital), Giedre Krenciute(St. Jude Children's Research Hospital), Heather Sheppard(St. Jude Children's Research Hospital), Jason Chiang(St. Jude Children's Research Hospital), Michaela Meehl(St. Jude Children's Research Hospital), Deanna Langfitt(St. Jude Children's Research Hospital), Alisha Kardian(Baylor College of Medicine), Siri Ippagunta(St. Jude Children's Research Hospital), Diana Dinh(St. Jude Children's Research Hospital), Srinidhi Varadharajan(Baylor College of Medicine), Jorge Ibañez-Vega(St. Jude Children's Research Hospital), Wilda Orisme(St. Jude Children's Research Hospital), Meghan B. Ward(St. Jude Children's Research Hospital), Jeffrey Steinberg(St. Jude Children's Research Hospital), Stephen C. Mack(St. Jude Children's Research Hospital), David W. Ellison(St. Jude Children's Research Hospital), Shannon Lange(St. Jude Children's Research Hospital), Amber B. Jones(St. Jude Children's Research Hospital), Erik Emanus(St. Jude Children's Research Hospital), Peter Vogel(Lexicon Pharmaceuticals (United States)), Nic Laboe(St. Jude Children's Research Hospital), Tram Dao(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Germline Mutations in Predisposition Genes in Pediatric Cancer
|New England Journal of Medicine|2015|1.4k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853